-+ 0.00%
-+ 0.00%
-+ 0.00%

Kangyuan Pharmaceutical (600557.SH) released semi-annual results, with net profit of 147 million yuan to mother, an increase of 3.36% over the previous year

Zhitongcaijing·08/27/2026 08:57:04
Listen to the news

According to Zhitong Finance App News, Kangyuan Pharmaceutical (600557.SH) disclosed its 2026 semi-annual report. During the reporting period, the company achieved operating income of 1,661 billion yuan, up 1.21% year on year; net profit attributable to shareholders of listed companies was 147 million yuan, up 3.36% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 129 million yuan, up 7.46% year on year; basic earnings per share were 0.26 yuan.